2nd Quarter - Termination

MEDLINE for MEDLINE

Period 2nd Quarter 2013 Filed Jul 22, 2013 Signed by Robert Calia, Government Affairs Specialist

Official filing
Firm
MEDLINE
Client
MEDLINE
Income
—
Expenses
$20,000
Expense method
A: Lobbying Disclosure Act definitions
Terminated
Apr 1, 2013

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to pharmaceutical supply chain security including H.R. 1919 - Safeguarding America's Pharmaceuticals Act and S. 957 - Drug Supply Chain Security Act; Issues related to the medical device tax, including H.R. 523 - Protect Medical Innovation Act of 2013.

LobbyistCovered position, as disclosed
ROBERT CALIA Confidential Assistant, Department of Commerce

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1919 (113th), H.R. 523 (113th), S. 957 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.